Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Astrocytes respond to insult with a process of cellular activation known as reactive astrogliosis. One of the key signals regulating this phenomenon is the transcription factor nuclear factor‐kappa B (NF‐κB), which is responsible for modulating inflammation, cell survival, and cell death. In astrocytes, following trauma or disease, the expression of NF‐κB‐dependent genes is highly activated. We previously demonstrated that inactivation of astroglial NF‐κB in vivo (GFAP‐IκBα‐dn mice) leads to improved functional outcome in experimental autoimmune encephalomyelitis (EAE), and this is accompanied by reduction of pro‐inflammatory gene expression in the CNS. Here we extend our studies to show that recovery from EAE in GFAP‐IκBα‐dn mice is associated with reduction of peripheral immune cell infiltration into the CNS at the chronic phase of EAE. This is not dependent on a less permeable blood‐brain barrier, but rather on a reduced immune cell mobilization from the periphery. Furthermore, once inside the CNS, the ability of T cells to produce pro‐inflammatory cytokines is diminished during acute disease. In parallel, we found that the number of total and activated microglial cells is reduced, suggesting that functional improvement in GFAP‐IκBα‐dn mice is dependent upon reduction of the overall inflammatory response within the CNS sustained by both resident and infiltrating cells. This results in preservation of myelin compaction and enhanced remyelination, as shown by electron microscopy analysis of the spinal cord. Collectively our data indicate that astrocytes are key players in driving CNS inflammation and are directly implicated in the pathophysiology of EAE, since blocking their pro‐inflammatory capability results in protection from the disease. GLIA 2014;62:452–467
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“Since MHCII, which is upregulated during microglial activation (Kreutzberg, 1996), is indispensable for the antigen presentation process (Almolda et al., 2011), this suggests a reduced immune engagement capability of this cell population as APCs.”
BackgroundThe Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · cited 5×
“Inhibition of NF-jB in Astrocytes Does Not Alter Blood-Spinal Barrier (BSB) Permeability Since astrocytes are integral components of the BBB and the BSB (Zlokovic, 2008), and NF-jB is a key transcriptional regulator of genes implicated in BBB/BSB architecture and function (Dietrich, 2002; Roebuck and Finnegan, 1999),…”
BackgroundInfluentialSize-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917 · cited 1×
“Claudin-5, a major cell adhesion molecule of tight junctions in CNS endothelial cells, is essential for BBB function, and loss of claudin-5 is associated with loosening of the BBB (Nitta et al., 2003).”
BackgroundAstrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304 · cited 2×
“Specifically CCL2, which is highly produced by astrocytes (Farina et al., 2007; Kuboyama et al., 2011; Zaritsky et al., 2012) and directly regulated by NF-jB (Bonello et al., 2011; Giraud et al., 2010; Kuboyama et al., 2011), is an important chemo-attractant factor for monocytes and T cells (Daly…”
BackgroundRegulation of hypoxia-inducible factor-1α by NF-κB
van Uden, P., Kenneth, N. S., & Rocha, S. (2008) · Biochemical Journal · doi:10.1042/bj20080476 · Cited by 729
Glial cells in (patho)physiology
Parpura, V., Heneka, M. T., Montana, V., Oliet, S. H. R., Schousboe, A., Haydon, P. G., Stout, R. F., Spray, D. C., Reichenbach, A., Pannicke, T., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07664.x · Cited by 561 · cited 2×
“In recent years the contribution of astrocytes to the initiationand progression of most neurodegenerative disorders has been widely reported (Braak et al., 2007; Parpura et al., 2012; Rappold and Tieu, 2010; Song et al., 2009; Verkhratsky et al., 2010).”
BackgroundBraak, H., Sastre, M., & Del Tredici, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0244-3 · Cited by 462 · cited 2×
“In recent years the contribution of astrocytes to the initiationand progression of most neurodegenerative disorders has been widely reported (Braak et al., 2007; Parpura et al., 2012; Rappold and Tieu, 2010; Song et al., 2009; Verkhratsky et al., 2010).”
BackgroundKang, Z., Altuntas, C. Z., Gulen, M. F., Liu, C., Giltiay, N., Qin, H., Liu, L., Qian, W., Ransohoff, R. M., Bergmann, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.004 · Cited by 297 · cited 1×
“More recently, astrocytes participating in BBB formation have been reported as the first cells in the CNS to be activated by MOG-reactive Th17 cells and to produce pro-inflammatory cytokines and chemokines that are essential for EAE induction (Kang et al., 2010).”
BackgroundColombo, E., Cordiglieri, C., Melli, G., Newcombe, J., Krumbholz, M., Parada, L. F., Medico, E., Hohlfeld, R., Meinl, E., & Farina, C. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20110698 · Cited by 146
Raasch, J., Zeller, N., van Loo, G., Merkler, D., Mildner, A., Erny, D., Knobeloch, K.-P., Bethea, J. R., Waisman, A., Knust, M., et al. (2011) · Brain · doi:10.1093/brain/awq359 · Cited by 106 · cited 1×
“…described (Brambilla et al., 2005), and extensively characterized under physiological conditions and in various models of neurodegenerative diseases (Brambilla et al., 2005, 2012, 2009; Dvoriantchikova et al., 2009; Fu et al., 2010; Morton et al., 2012; Raasch et al., 2011; Zhang et al., 2011).”
BackgroundSelf-citation
Cited by
Astrocyte Crosstalk in CNS Inflammation
Linnerbauer, M., Wheeler, M. A., & Quintana, F. J. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.012 · Cited by 989
“For example, nuclear translocation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) heterodimer is a central step in astrocyte activation and contributes to the progression of EAE and other CNS pathologies (Blank and Prinz, 2014; Brambilla et al., 2005; Brambilla et al., 2012; Brambilla et…”
BackgroundAstrocytes: Key Regulators of Neuroinflammation
Colombo, E., & Farina, C. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.06.006 · Cited by 904
Function and therapeutic value of astrocytes in neurological diseases
Lee, H.-G., Wheeler, M. A., & Quintana, F. J. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00390-x · Cited by 662
Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair
Domingues, H. S., Portugal, C. C., Socodato, R., & Relvas, J. B. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00071 · Cited by 432
Brambilla, R. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01980-7 · Cited by 246
Self-citationMultiple sclerosis and cognition: synaptic failure and network dysfunction
Di Filippo, M., Portaccio, E., Mancini, A., & Calabresi, P. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0053-9 · Cited by 205
Hennessy, E., Griffin, É. W., & Cunningham, C. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2745-14.2015 · Cited by 178
“Similarly, astrocytic NF B inhibition decreases chemokine expression (Brambilla et al., 2014) and it is plausible that increased astrocytic expression of NF B subunits, and consequent increased transcriptional activation, may underpin exaggerated astrocyte responses to acute stimulation.”
BackgroundMadsen, P. M., Motti, D., Karmally, S., Szymkowski, D. E., Lambertsen, K. L., Bethea, J. R., & Brambilla, R. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0211-16.2016 · Cited by 161
Self-citationSignaling pathways regulating neuron–glia interaction and their implications in Alzheimer's disease
Lian, H., & Zheng, H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13424 · Cited by 77
Zimmer, T. S., Broekaart, D. W. M., Gruber, V.-E., van Vliet, E. A., Mühlebner, A., & Aronica, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01028 · Cited by 48
“Moreover, astrocyte-specific NFκB activation in TSC might also play a role in suppressing myelination (248).”
Cellular Senescence in Glial Cells: Implications for Multiple Sclerosis
Maupin, E. A., & Adams, K. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16301 · Cited by 12
Scalabrino, G. (2022) · Biomedicines · doi:10.3390/biomedicines10040815 · Cited by 10
Metadata
- Authors
- Brambilla, R., Morton, P. D., Ashbaugh, J. J., Karmally, S., Lambertsen, K. L., & Bethea, J. R.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2013-12-19
- Volume
- 62
- Issue
- 3
- Pages
- 452-467
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W1860574066
- Cited by
- 154
- References
- 10
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.